vimizim Search Results


vimizim  (BioMarin Inc)
90
BioMarin Inc vimizim
Agents pending FDA approval: May 18, 2013 through July 17, 2013
Vimizim, supplied by BioMarin Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vimizim/product/BioMarin Inc
Average 90 stars, based on 1 article reviews
vimizim - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
elosulfase alfa vimizim  (BioMarin Inc)
90
BioMarin Inc elosulfase alfa vimizim
Agents pending FDA approval: May 18, 2013 through July 17, 2013
Elosulfase Alfa Vimizim, supplied by BioMarin Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elosulfase alfa vimizim/product/BioMarin Inc
Average 90 stars, based on 1 article reviews
elosulfase alfa vimizim - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Agents pending FDA approval: May 18, 2013 through July 17, 2013

Journal: Hospital Pharmacy

Article Title: Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals

doi: 10.1310/hpj4808-682

Figure Lengend Snippet: Agents pending FDA approval: May 18, 2013 through July 17, 2013

Article Snippet: Elosulfase alfa , Vimizim (BioMarin Pharmaceutical) , Treatment of patients suffering from mucopolysaccharidosis type IVA (MPS IVA) or morquio A syndrome. Priority review, but the date on which the agency will announce drug approval status was delayed by 3 months at the end of May 2013..

Techniques: Injection, Formulation